top of page
    • Dec 9, 2020
    • 1 min read

Biopharma Stock Updates - 12/09/20

Data Updates:

$GMDA (-13.3%) – Topline phase 3 results & BLA plans

$CYTK (+22.8%) – Phase 2 interim analysis – proceed to cohort 2

$ATNX (-3.3%) – Updated phase 3 data for oraxol

$EDIT (+17%) – Submitted IND for EDIT-301 in SCD

$FPRX (-12.5%) – Will present phase 2 data at ASCO 01/15/21

$GTHX (-7.5%) – Phase 2 data for Triliciclib and phase 1 update

Financial:

$KURA (-1.2%) – Priced their offering at $37/share

$SNDX (+7%) – Priced their offering at $23/share

$MIRM (+0.67%) - $210 million funding arrangement – tiered revenue-based

0 comments
bottom of page